115 related articles for article (PubMed ID: 16267761)
21. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study.
Khameneh ZR
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):41-5. PubMed ID: 18087121
[TBL] [Abstract][Full Text] [Related]
23. Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance.
Altimari A; Gruppioni E; Capizzi E; Bagni A; Corti B; Fiorentino M; Lazzarotto T; Lauro A; Pinna AD; Ridolfi L; Grigioni WF; D'errico-Grigioni A
Transplantation; 2008 Jun; 85(12):1778-83. PubMed ID: 18580471
[TBL] [Abstract][Full Text] [Related]
24. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
[TBL] [Abstract][Full Text] [Related]
26. [Human herpes virus 6 infection in renal transplant recipient--case report].
Deborska-Materkowska D; Sadowska A; Matłosz B; Zegarska J; Durlik M
Przegl Epidemiol; 2006; 60(1):141-6. PubMed ID: 16758753
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection.
Classen CF; Bird PI; Debatin KM
Clin Exp Immunol; 2006 Mar; 143(3):534-42. PubMed ID: 16487253
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy.
D'Ovidio V; Vernia P; Gentile G; Capobianchi A; Marcheggiano A; Viscido A; Martino P; Caprilli R
J Clin Virol; 2008 Oct; 43(2):180-3. PubMed ID: 18614396
[TBL] [Abstract][Full Text] [Related]
29. Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant.
Cashion A; Sabek O; Driscoll C; Gaber L; Kotb M; Gaber O
Clin Transplant; 2006; 20(1):106-12. PubMed ID: 16556164
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.
Veale JL; Liang LW; Zhang Q; Gjertson DW; Du Z; Bloomquist EW; Jia J; Qian L; Wilkinson AH; Danovitch GM; Pham PT; Rosenthal JT; Lassman CR; Braun J; Reed EF; Gritsch HA
Hum Immunol; 2006 Oct; 67(10):777-86. PubMed ID: 17055354
[TBL] [Abstract][Full Text] [Related]
31. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
Helanterä I; Koskinen P; Finne P; Loginov R; Kyllönen L; Salmela K; Grönhagen-Riska C; Lautenschlager I
Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection.
Helanterä I; Loginov R; Koskinen P; Lautenschlager I
Transpl Int; 2008 Oct; 21(10):980-4. PubMed ID: 18564986
[TBL] [Abstract][Full Text] [Related]
33. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
[TBL] [Abstract][Full Text] [Related]
34. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
Cummins NW; Deziel PJ; Abraham RS; Razonable RR
Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
[TBL] [Abstract][Full Text] [Related]
36. CD8+ T-cell maturation following lung transplantation: the differential impact of CMV and acute rejection.
Westall GP; Brooks AG; Kotsimbos T
Transpl Immunol; 2007 Nov; 18(2):186-92. PubMed ID: 18005866
[TBL] [Abstract][Full Text] [Related]
37. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
38. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
[TBL] [Abstract][Full Text] [Related]
39. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
[TBL] [Abstract][Full Text] [Related]
40. Patterns of human cytomegalovirus infection in term placentas: a preliminary analysis.
McDonagh S; Maidji E; Chang HT; Pereira L
J Clin Virol; 2006 Feb; 35(2):210-5. PubMed ID: 16386950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
